Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
Experts urge early detection & better access to care
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
Biocon Foundation has been steadfast in its mission to empower underserved communities through innovative healthcare solutions, education, and sustainable development initiatives
Subscribe To Our Newsletter & Stay Updated
